Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study

被引：0
|
作者：
Hartmann, K. [1 ]
Broesby-Olsen, S. [2 ]
Siebenhaar, F. [3 ,4 ,5 ,6 ]
Elberink, H. O. [7 ]
Gotlib, J. [8 ]
Sabato, V [9 ,10 ]
Castells, M. [11 ]
Deininger, M. W. [12 ]
Heaney, M. L. [13 ]
George, T., I [11 ,12 ]
Radia, D. H. [14 ]
Triggiani, M. [15 ]
Van Daele, P. [16 ]
Deangelo, D. J. [17 ]
Schmidt-Kittler, O. [18 ]
Lin, H. [18 ]
Morrison, A. [18 ]
Mar, B. [18 ]
Akin, C. [19 ]
Maurer, M. [3 ,4 ,5 ,6 ]
机构：
[1] Univ Basel, Basel, Switzerland
[2] Odense Univ Hosp, Odense, Denmark
[3] Charite Univ Med Berlin, Berlin, Germany
[4] Free Univ Berlin, Berlin, Germany
[5] Humboldt Univ, Berlin, Germany
[6] Berlin Inst Hlth, Berlin, Germany
[7] Univ Med Ctr Groningen, Groningen, Netherlands
[8] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA
[9] Univ Antwerp, Antwerp, Belgium
[10] Antwerp Univ Hosp, Antwerp, Belgium
[11] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[12] Univ Utah, Salt Lake City, UT USA
[13] Columbia Univ, Med Ctr, New York, NY USA
[14] Guys & St Thomass NHS Fdn Trust, London, England
[15] Univ Salerno, Salerno, Italy
[16] Erasmus MC, Rotterdam, Netherlands
[17] Dana Farber Canc Inst, Boston, MA 02115 USA
[18] Blueprint Med Corp, Cambridge, MA USA
[19] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
ALLERGY | 2020年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
1832
引用
收藏
页码：111 / 111
页数：1
相关论文
共 33 条
  • [21] Bone marrow mast cell burden and serum tryptase level as markers of response in patients with systemic mastocytosis
    Quintas-Cardama, Alfonso
    Sever, Matjaz
    Cortes, Jorge
    Kantarjian, Hagop
    Verstovsek, Srdan
    LEUKEMIA & LYMPHOMA, 2013, 54 (09) : 1959 - 1964
  • [22] Elenestinib, an Investigational, Next Generation KIT D816V Inhibitor, Reduces Mast Cell Burden, Improves Symptoms, and Has a Favorable Safety Profile in Patients with Indolent Systemic Mastocytosis: Analysis of the Harbor Trial
    Tashi, Tsewang
    Hermine, Olivier
    Castells, Mariana
    Guilarte, Mar
    Sabato, Vito
    Maurer, Marcus
    Panse, Jens
    Alvarez-Twose, Ivan
    Cabral, Renata
    Bird, Robert
    Barete, Stephane
    Bouillet, Laurence
    Hermans, Maud
    Van Daele, Paul
    Gonzalez-De-Olano, David
    Griffiths, Elizabeth A.
    Jurcic, Joseph
    Dybedal, Ingunn
    Damaj, Gandhi Laurent
    Schafhausen, Philippe
    Elena, Chiara
    Teh, Tse-Chieh
    Vachhani, Pankit
    Labe, Caroline
    Venugopal, Saranya
    He, Kevin
    Munoz-Gonzalez, Javier
    Lampson, Ben
    Scherber, Robyn
    Bose, Prithviraj
    Grattan, Clive
    Pongdee, Thanai
    George, Tracy I.
    Livideanu, Cristina Bulai
    BLOOD, 2023, 142
  • [23] Change In Mast Cell Bone Marrow Burden and In Serum Tryptase Level Are Not Accurate Markers of Response In Patients with Systemic Mastocytosis
    Quintas-Cardama, Alfonso
    Sever, Matjaz
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    BLOOD, 2010, 116 (21) : 1267 - 1268
  • [24] A Snapshot Audit of Symptom Burden in Patients with Indolent Systemic Mastocytosis Utilising the ISM-SAF © within a UK Centre of Excellence: Guy's and St Thomas' NHS Foundation Trust
    Veitch, Scott
    Asirvatham, Susan
    Sriskandarajah, Priya
    Saha, Chandan
    Oni, Clare
    Grattan, Clive
    Radia, Deepti H.
    BLOOD, 2023, 142
  • [25] Evidence for a common progenitor for monocytes, B-lymphocytes and mast cells by single cell mutational analysis of cells in the peripheral blood of patients with systemic indolent mastocytosis.
    Yavuz, AS
    Lipsky, PE
    Metcalfe, DD
    Akin, C
    BLOOD, 2000, 96 (11) : 806A - 806A
  • [26] Frequency of mast cell-mediator release symptoms during anaesthesia in patients with mastocytosis: a retrospective study in 148 anaesthetic procedures by the Spanish network on mastocytosis (REMA)
    Matitio, A.
    Alvarez-Twose, I
    Sanchez Mua'oz, L.
    Manzanero, M.
    Escribano, L.
    ALLERGY, 2010, 65 : 345 - 346
  • [27] The Systemic Effects of Vorinostat in Patients (Pts) with Cutaneous T-Cell Lymphoma (CTCL): Post-Hoc Analyses in Pts with High Blood Tumor Burden.
    Duvic, Madeleine
    Kim, Youn H.
    Kuzel, Timothy M.
    Pacheco, Theresa R.
    Foss, Francine M.
    Parker, Sareeta
    Rizvi, Syed
    Chen, Cong
    Arduino, Jean Marie
    Olsen, Elise A.
    BLOOD, 2009, 114 (22) : 681 - 681
  • [28] KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders:: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients
    Garcia-Montero, Andres C.
    Jara-Acevedo, Maria
    Teodosio, Cristina
    Luz Sanchez, Maria
    Nunez, Rosa
    Prados, Aranzazu
    Aldanondo, Isabel
    Sanchez, Laura
    Dominguez, Mercedes
    Botana, Luis M.
    Sanchez-Jimenez, Francisca
    Sotlar, Karl
    Almeida, Julia
    Escribano, Luis
    Orfao, Alberto
    BLOOD, 2006, 108 (07) : 2366 - 2372
  • [29] Increased Detection of KIT D816V Mutation in Peripheral Blood Samples from Patients with Indolent Systemic Mastocytosis (ISM) in the Phase 2 Pioneer Study Using a High Sensitivity Droplet Digital (dd) PCR Assay Compared with Next Generation Sequencing (NGS)
    George, Tracy I.
    Hoehn, Gerard
    Lin, Hui-Min
    Miller, Stephen
    Akin, Cem
    BLOOD, 2020, 136
  • [30] A Clinicopathologic Study of 24 Cases of Systemic Mastocytosis Involving the Gastrointestinal Tract and Assessment of Mucosal Mast Cell Density in Irritable Bowel Syndrome and Asymptomatic Patients
    Doyle, Leona A.
    Sepehr, Golrokh J.
    Hamilton, Matthew J.
    Akin, Cem
    Castells, Mariana C.
    Hornick, Jason L.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (06) : 832 - 843
1234